Hydrochlorure de Procaterol,

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

β₂-adrenoceptor agonist; bronchodilator.

Features and Benefits

This compound was developed by Pfizer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is featured on the β-Adrenoceptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

General description

Procaterol is used to prevent lung fibroblast migration. It has anti-inflammatory properties. It can block type 2 T helper (Th2)-related chemokine production in human monocytes and bronchial epithelial cells.

Packaging

Bottomless glass bottle. Contents are inside inserted fused cone.